XTX Topco’s Aquestive Therapeutics AQST Stock Holding History

XTX Topco’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$325K	Buy	+78,341	New	+$318K	0.01%	2419
2025 Q4	–	Sell	-60,776	Closed	-$340K	–	3299
2025 Q3	$340K	Buy	60,776 +46,142	+315%	+$200K	0.02%	1411
2025 Q2	$48.4K	Sell	14,634 -63,888	-81%	-$183K	﹤0.01%	2019
2025 Q1	$228K	Buy	+78,522	New	+$238K	0.01%	1608
2024 Q2	–	Sell	-11,618	Closed	-$49.5K	–	1841
2024 Q1	$49.5K	Buy	+11,618	New	+$38.7K	0.01%	1476
2023 Q4	–	Sell	-52,980	Closed	-$81.1K	–	1566
2023 Q3	$81.1K	Sell	52,980 -85,165	-62%	-$146K	0.01%	1212
2023 Q2	$228K	Buy	+138,145	New	+$250K	0.04%	922
2021 Q2	–	Sell	-10,970	Closed	-$57K	–	791
2021 Q1	$57K	Buy	+10,970	New	+$58.4K	0.03%	613

Other funds holding AQST

BCM

Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

XTX Topco's AQST Position: Q1 2026 in Review

XTX Topco opened a new position in Aquestive Therapeutics (AQST) in Q1 2026: 78,341 shares worth $325K. The stake represents 0.01% of the portfolio and ranks #2419 among its holdings. This is a return to the name: XTX Topco previously reported a position in AQST as recently as Q3 2025.

XTX Topco first reported a position in AQST in Q1 2021 and has held it in 8 quarters since. The position peaked at $340K in Q3 2025. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

XTX Topco held 78,341 shares of Aquestive Therapeutics worth $325K as of Q1 2026.
Aquestive Therapeutics was a new XTX Topco position in Q1 2026.
Aquestive Therapeutics made up 0.01% of XTX Topco's portfolio in Q1 2026, its #2419 holding.
XTX Topco first reported a position in Aquestive Therapeutics in Q1 2021 and has held it in 8 quarters since.
XTX Topco's Aquestive Therapeutics position peaked at $340K in Q3 2025.
179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.